SynthesisFrontiers in oncology2024

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review.

Lingbo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.